Pharmaceutical composition for treating infantile cerebral palsy

A technology for children with cerebral palsy and a composition is applied in the field of pharmaceutical compositions for the treatment of children with cerebral palsy and its preparation, and can solve the problems of high price, poor effect, treating the symptoms but not the root cause, and the like

Inactive Publication Date: 2016-04-20
JINAN XINGYI MEDICAL TECH
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Existing treatments for cerebral palsy are poorly effective and expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating infantile cerebral palsy
  • Pharmaceutical composition for treating infantile cerebral palsy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1: the pharmaceutical composition and preparation method thereof for the treatment of infantile cerebral palsy

[0035] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating children with cerebral palsy are: 2940 g of Oysterwort, 1250 g of Pteroside, 75 g of Pteroside, 450 g of Barkweed, and 315 g of Fernia officinalis;

[0036] Preparation:

[0037] (1) According to the ratio of raw materials, take oyster vegetables, Eustoma wood, pteroside, arboriferium, and dwarf fern, mix them evenly, use ethanol with a concentration of 24% by weight as a solvent, and extract them by warm soaking at 32°C. The number of times is 19 times, each extraction time is 1.2 hours, and the amount of solvent used each time is 41 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovers ethanol, concentrates to a relative density of 1.20, Filtration, the medicinal li...

Embodiment 2

[0040] Embodiment 2: the pharmaceutical composition and preparation method thereof for the treatment of infantile cerebral palsy

[0041] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating children with cerebral palsy are: 2900g Eurasian oyster, 1300g Pteroside 70g, 480g Barkweed 480g, 300g Pteridoside;

[0042] Preparation:

[0043] (1) According to the ratio of raw materials, take oyster vegetables, Eustoma wood, pteroside, arboriferium, and dwarf fern, mix them evenly, use ethanol with a concentration of 24% by weight as a solvent, and extract them by warm soaking at 32°C. The number of times is 19 times, each extraction time is 1.2 hours, and the amount of solvent used each time is 41 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovers ethanol, concentrates to a relative density of 1.20, Filtration, the medicinal liquid passes through the HP30 mac...

Embodiment 3

[0046] Embodiment 3: the pharmaceutical composition and preparation method thereof for the treatment of infantile cerebral palsy

[0047] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating children with cerebral palsy are: 2980g Eustoma japonica 1200g 80g pterostalloside 80g barkweed 420g 330g broken line fern;

[0048] Preparation:

[0049] (1) According to the ratio of raw materials, take oyster vegetables, Eustoma wood, pteroside, arboriferium, and dwarf fern, mix them evenly, use ethanol with a concentration of 24% by weight as a solvent, and extract them by warm soaking at 32°C. The number of times is 19 times, each extraction time is 1.2 hours, and the amount of solvent used each time is 41 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovers ethanol, concentrates to a relative density of 1.20, Filtration, the medicinal liquid passes through the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating infantile cerebral palsy and a preparation method thereof. The pharmaceutical composition is prepared by matching the raw materials of kelp, twigs and leaves of Japanese eurya, trifolirhizin, crateva unilocularis Buch.Ham.[C.religiosa auct.non Forst.f.] and shining colysis. The pharmaceutical composition can be prepared into various preparations according to a conventional preparation technology, and the curative effect on treating the infantile cerebral palsy is significant.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating children with cerebral palsy and a preparation method thereof. Background technique [0002] It is well known that there is no effective treatment for children with cerebral palsy. The incidence of this disease has an annual increasing trend, and the worldwide incidence rate is 1%-4%. The incidence rate in our country is 2%. There are about 6 million cerebral palsy patients in the whole country. Children under the age of 12 have 120,000 yuan. The extremely expensive treatment costs not only affect the treatment results, but also drag down many families due to the long treatment time. Bring heavy economic and spiritual burden to many families. The current treatment of children with cerebral palsy includes western medicine and surgery! Rehabilitation treatment, stem cell therapy and other alcohol and drug treatments ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/82A61P25/00A61K31/7048
CPCA61K36/11A61K9/1652A61K9/2031A61K9/2059A61K9/4866A61K31/7048A61K36/02A61K36/185A61K36/82A61K2236/333A61K2236/39A61K2236/55
Inventor 不公告发明人
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap